Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
JUNSHI BIO Places Shrs at 11.5% Discount to Raise Net HKD1.03B
Recommend 3 Positive 4 Negative 6 |
||||
|
||||
|
JUNSHI BIO (01877.HK) announced a placement of 41 million shares (15.75% of the company's enlarged issued H-shares and 3.99% of its total issued shares) at a price of HKD25.35 per share, marking a discount of about 11.52% to yesterday's (12th) closing price of HKD28.65. The placement is expected to raise net proceeds of around HKD1.026 billion, around 70% of which will be used for innovative drug development, including anti-PD-1/VEGF bispecific antibody (code JS207), epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 3 (HER3) bispecific antibody-drug conjugate (code JS212), PD-1 and interleukin-2 (IL-2) bifunctional antibody fusion protein (code JS213), and other pipelines under development. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
